A leading UK virtual healthcare provider specializing in Cannabis-Based Products for Medicinal Use (CBPMs) and dissociative anesthetics is looking to sell their business. They offer a fully compliant, telehealth platform with services across patient care, prescribing, professional education, and a digital infrastructure. With operations in the UK and a European subsidiary in Prague, this is a turnkey opportunity for expanding into the growing cannabinoid medicine market.
Business Highlights:
- Fully Virtual, Turnkey Model: This CQC-registered healthcare provider delivers secure, virtual consultations and prescriptions for both licensed and unlicensed medicines, including CBPMs and psychedelics.
- A Proven Clinical Team: They have a network of 12 authorized medical professionals, including specialists in pain, psychiatry, ADHD, rheumatology, GPs, and prescribing nurses.
- Proprietary Technology: Includes secure patient portal, online booking and payment system, doctor collaboration platform, CPD-accredited education portal, and clinic/corporate websites.
- Prescribing Scope: Clear protocols for prescribing CBPMs, including eligibility assessments, team reviews, follow-ups, and general prescription services. Physical examinations will be referred as needed.
- Support Network: Has an exclusive agreement with a major Type 1 cannabis importer, collaborations with over 28 supply partners, and two pharmacy partners for direct-to-patient distribution.
Additional Benefits:
- Authorized to prescribe to UK patients aged 18+
- Multiple revenue streams: patients, pharmacies, education
- Projected £4.17M revenue for FY 2025
- Set up for clinical trials with NHS and top UK universities
- NHS Services List application in progress for faster patient access
- Cyber Essentials certification pending
- EU expansion ready via Prague-based subsidiary
Business Opportunity:
This business opportunity offers a fully operational, accredited virtual clinic with a strong foothold in the UK’s medical cannabis and psychedelic medicine sector. With an experienced clinical team, proprietary telehealth technology, multiple revenue streams, and a clear path to expansion in the EU, the business is perfectly positioned for growth in the healthcare market.
